Incyte Corporation

Craig H Ison

Henry Yue

Mariah R Baughn

April J A Hafalia

Ameena R Gandhi

Monique G Yao

Yan Lu

Anita Swarnakar

Olga Bandman

Neil Burford

Li Ding

Vicki S Elliott

Preeti G Lal

Y Tom Tang

Dyung Aina M Lu

Bridget A Warren

Yuming Xu

Danniel B Nguyen

Junming Yang

Bao M Tran

Brendan M Duggan

Rajagopal Gururajan

Sally Lee

Michael B Thornton

Kimberly J Gietzen

Madhusudan M Sanjanwala

Michael Thorton

Cynthia D Honchell

Narinder K Chawla

Ian J Forsythe

Ernestine A Lee

Wen Luo

Uyen K Tran

Pei Jin

Reena Khare

Thomas W Richardson

Narinder K Walia

Joseph P Marquis

Shanya D Becha

Soo Yeun Lee

Kavitha Thangaveln

Joana X Li

Amy D Wilson

Stephanie Kareht

Kavitha Thangavelu

Narinder K Chawla-Walia

Chandra S Arvizu

Catherine M Tribouley

Jayalaxmi Ramkumar

Stephanie K Sapperstein

Vicki S Kaulback

Janice K Au-Young

Yalda Azimzai

Gregory Marcus

Farrah A Khan

Jennifer L Policky

Liam Kearney

John D Burrill

Vicki S Elliott Kaulback

Kurt A Zingler

Preeti G Lai

Jennifer A Griffin

The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Secreted proteins

Antibody to secreted polypeptide

Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Antibodies to human &#x3b2;-adrenergic receptor kinase

Human &#x3b2;-adrenergic receptor kinase polypeptide and methods

Various embodiments of the invention provide human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Human &#x3b2;-adrenergic receptor kinase nucleic acid molecule

The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.

Human cAMP-dependent protein kinase beta-catalytic subunit

The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.

Human protein phosphatase 2C

Growing community of inventors

San Jose, CA, United States of America

Craig H Ison